Slider Consumer Healthcare

Research & Development

Research & Development at Menarini

For more than 30 years, Menarini has driven research and development to create innovative and effective medicines and healthcare solutions for patients with serious diseases. At Menarini, we know that patients' hope for a better life is inextricably linked to the perseverance and progress of our researchers. This is what drives us. With 10 research centers in Europe, the US and Southeast Asia, MENARINI R&D develops projects from the preclinical phase to drug approval.

AT-WEB-35-10-2021

menarini-austria-forschung


Our approach to R&D

Our R&D department focuses on developing life science innovations to improve patient health. Working with our Business Development & Licensing and Marketing teams, we identify the most promising opportunities and apply our drug development expertise to transform them into high-quality medicines that improve patients' lives. Continuous investment in technologies and in improving the skills and knowledge of our researchers enables us to achieve scientific breakthroughs and make an important contribution to curing difficult-to-treat diseases.

READ MORE ON OUR GLOBAL WEBSITE


Innovation & Research

We are highly committed to developing effective solutions to address the global threat associated with antimicrobial resistance. Discover more about our R&D projects in the anti-infectives area.

Read More

Dear visitor, the gender form selected on our homepage always refers to female, male and various people at the same time. We have refrained from using a gender-specific spelling or multiple designations solely for the purpose of better readability. All personal designations are to be understood as gender-neutral.

Liebe Besucherin, lieber Besucher, die auf unserer Homepage gewählte Geschlechtsform bezieht sich immer zugleich auf weibliche, männliche und diverse Personen. Wir haben ausschließlich zum Zweck der besseren Lesbarkeit auf eine geschlechtsspezifische Schreibweise bzw. auf eine Mehrfachbezeichnung verzichtet. Alle personenbezogenen Bezeichnungen sind geschlechtsneutral zu verstehen.